We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
77 hedge funds and large institutions have $45.4M invested in Larimar Therapeutics in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
40% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 10
15% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 20
5% more funds holding
Funds holding: 73 → 77 (+4)
56% less capital invested
Capital invested by funds: $103M → $45.4M (-$57.4M)
59% less call options, than puts
Call options by funds: $266K | Put options by funds: $655K
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
77
Holders Change
+4
Holders Change %
+5.48%
% of All Funds
2.05%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
14
Increased
23
Reduced
20
Closed
10
Calls
$266K
Puts
$655K
Net Calls
-$389K
Net Calls Change
-$1.39M
Top Buyers
| 1 |
RA
Royce & Associates
New York
|
+$1.91M |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$902K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$823K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$745K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$561K |